166 related articles for article (PubMed ID: 4017475)
1. [Use of ciclonicate in the treatment of obliterative arteriopathies of the lower limbs].
Licata G; Pinto A; Parrinello G; Salli L; Indovina I
Clin Ter; 1985 Mar; 112(6):503-13. PubMed ID: 4017475
[No Abstract] [Full Text] [Related]
2. [Clinico-instrumental evaluation of ciclonicate in the therapy of obliterating arteriopathies of the lower extremities in Fontaine's stage II].
Feliciotti F; De Carolis G; Mariotti C; Mingolla F
Ann Ital Chir; 1983; 55(5):493-7. PubMed ID: 6673630
[No Abstract] [Full Text] [Related]
3. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
di Giovanna VN
Clin Ter; 1988 Jun; 125(6):431-4. PubMed ID: 2973949
[No Abstract] [Full Text] [Related]
4. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
Tallarida G; Baldoni F; Peruzzi G; Raimondi G; Grimaldi I; Visigalli G; Gristina S; Massaro M; De Martinis L; Sangiorgi M
Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
[No Abstract] [Full Text] [Related]
5. [The vasoactivogram in the treatment of peripheral arteriopathies].
Romeo S; Spinella G; Sciacchitanto D
Angiologia; 1975; 27(1):7-25. PubMed ID: 1111377
[No Abstract] [Full Text] [Related]
6. [Therapy of peripheral circulatory disorders using BAY b 7979, demonstrated through Tc-99m muscular clearance].
Nedjabat T; Ebinger H; Birtel FJ
Med Welt; 1976 Aug; 27(34):1585-7. PubMed ID: 948260
[No Abstract] [Full Text] [Related]
7. [Picotamide: use in chronic obliterative arteriopathies of the lower limbs].
Tazza G; Tazza R; Valentini M; Leoni G; Avenia N; Ragusa M
Clin Ter; 1991 Jun; 137(6):399-402. PubMed ID: 1832611
[TBL] [Abstract][Full Text] [Related]
8. Action of cinnarizine on the blood flow of the lower limbs in patients affected by obliterative peripheral arterial disease and in normal subjects.
Forconi S; Guerrini M; Di Perri T
Vasa; 1976; 5(4):360-5. PubMed ID: 1007545
[No Abstract] [Full Text] [Related]
9. Skin perfusion pressure and cutaneous blood flow in chronic obliterative arterial disease of the lower limbs.
Mirić G; Zdravković M
Acta Med Iugosl; 1988; 42(4):261-8. PubMed ID: 3213561
[No Abstract] [Full Text] [Related]
10. [Action of ifenprodil tartrate in obliterative arteriopathies of the lower limbs. Combined studies using proximal blood flow and distal transcutaneous oxygen pressure].
Costes Y; Pruniaux T; Roullier M; Bourgeois F; Flicoteaux H; Neidhardt A; Barale F
J Mal Vasc; 1986; 11(3):242-7. PubMed ID: 3772255
[TBL] [Abstract][Full Text] [Related]
11. [Effects of the nicotinic ester of 7(2-hydroxyethyl)-theophylline on peripheral arteriopathies in the aged].
Bandinelli G; De Mauro G; Provvedi D; Bellini PG; Rubegni M
Cardiol Prat; 1973; 24(3):275-80. PubMed ID: 4779825
[No Abstract] [Full Text] [Related]
12. [Experiences with the treatment of peripheral vascular diseases with Xavin].
Brücknerová O
Vnitr Lek; 1973 Apr; 19(4):379-86. PubMed ID: 4699159
[No Abstract] [Full Text] [Related]
13. [Effect of a transient intravenous infusion of isozsuprin on the peripheral blood flow in patients suffering from arterial occlusive disease of the limbs. A contribution to the effect of systemically-administered vasoactive drugs].
Ehringer H; Scheiber V
Wien Klin Wochenschr; 1972 Dec; 24(50):801-8. PubMed ID: 4642105
[No Abstract] [Full Text] [Related]
14. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
Schmidt C; Royer RJ; Kissel P
Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
[No Abstract] [Full Text] [Related]
15. [Evaluation of the efficacy of medical treatment, especially anticoagulant treatment, in arteriopathies of the lower limbs. Apropos of 41 cases].
Chérif T; Kallel N; Guediche M
Tunis Med; 1986 May; 64(5):475-80. PubMed ID: 3824555
[No Abstract] [Full Text] [Related]
16. [Effect of an infusion of piribedil in normal subjects and in patients with peripheral obliterating arterial disease on the blood flow of the lower limbs and on blood, plasma and serum viscosity].
Forconi S; Guerrini M; Agnusdei D; Di Perri T
Minerva Med; 1976 May; 67(25):1671-80. PubMed ID: 934519
[No Abstract] [Full Text] [Related]
17. [Internal conservative treatment of obliterative arteriopathies of the lower limbs].
Toth L
Med Pregl; 1975; 28(3-4):181-3. PubMed ID: 1177851
[No Abstract] [Full Text] [Related]
18. [Thermometry of the skin of the lower extremities in obliterative arterial diseases].
Varava BN; Ozerova OE; Molchanova LD
Sov Med; 1982; (2):103-6. PubMed ID: 7063958
[No Abstract] [Full Text] [Related]
19. [Pharmacodynamic study on nicotinic acid and of one of its higher homologs (3-pyridyl acetic acid) in obliterative arteriopathies of the extremities].
Spanò G; Saponaro A; Giordano G; Verde AM; Cosentino F; Dagianti A
Boll Soc Ital Cardiol; 1967; 12(2):148-53. PubMed ID: 5606866
[No Abstract] [Full Text] [Related]
20. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
Natali J; Kieny R; Le Bas P; Benhamou M; Molkhou JM
Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):339-42. PubMed ID: 2667444
[No Abstract] [Full Text] [Related]
[Next] [New Search]
